Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 114

1.

Computerised assistance for warfarin dosage--effects on treatment quality.

Dimberg I, Grzymala-Lubanski B, Hägerfelth A, Rosenqvist M, Svensson P, Själander A.

Eur J Intern Med. 2012 Dec;23(8):742-4. doi: 10.1016/j.ejim.2012.07.011. Epub 2012 Aug 20.

PMID:
22917757
2.

Anticoagulation control in Sweden: reports of time in therapeutic range, major bleeding, and thrombo-embolic complications from the national quality registry AuriculA.

Wieloch M, Själander A, Frykman V, Rosenqvist M, Eriksson N, Svensson PJ.

Eur Heart J. 2011 Sep;32(18):2282-9. doi: 10.1093/eurheartj/ehr134. Epub 2011 May 26.

3.

Computer aided warfarin dosing in the Swedish national quality registry AuriculA - Algorithmic suggestions are performing better than manually changed doses.

Grzymala-Lubanski B, Själander S, Renlund H, Svensson PJ, Själander A.

Thromb Res. 2013 Feb;131(2):130-4. doi: 10.1016/j.thromres.2012.11.016. Epub 2012 Dec 8.

PMID:
23232091
4.

Randomised comparison of a simple warfarin dosing algorithm versus a computerised anticoagulation management system for control of warfarin maintenance therapy.

Nieuwlaat R, Hubers LM, Spyropoulos AC, Eikelboom JW, Connolly BJ, Van Spall HG, Schulze KM, Cuddy SM, Stehouwer AC, Schulman S, Connolly SJ.

Thromb Haemost. 2012 Dec;108(6):1228-35. doi: 10.1160/TH12-06-0433. Epub 2012 Sep 26.

PMID:
23015161
5.

Variability of INR and its relationship with mortality, stroke, bleeding and hospitalisations in patients with atrial fibrillation.

Lind M, Fahlén M, Kosiborod M, Eliasson B, Odén A.

Thromb Res. 2012 Jan;129(1):32-5. doi: 10.1016/j.thromres.2011.07.004. Epub 2011 Aug 17.

PMID:
21851969
6.

Impact of global geographic region on time in therapeutic range on warfarin anticoagulant therapy: data from the ROCKET AF clinical trial.

Singer DE, Hellkamp AS, Piccini JP, Mahaffey KW, Lokhnygina Y, Pan G, Halperin JL, Becker RC, Breithardt G, Hankey GJ, Hacke W, Nessel CC, Patel MR, Califf RM, Fox KA; ROCKET AF Investigators.

J Am Heart Assoc. 2013 Feb 19;2(1):e000067. doi: 10.1161/JAHA.112.000067.

7.

Effect of a simple two-step warfarin dosing algorithm on anticoagulant control as measured by time in therapeutic range: a pilot study.

Kim YK, Nieuwlaat R, Connolly SJ, Schulman S, Meijer K, Raju N, Kaatz S, Eikelboom JW.

J Thromb Haemost. 2010 Jan;8(1):101-6. doi: 10.1111/j.1538-7836.2009.03652.x. Epub 2009 Oct 14.

8.

Variation in warfarin dose adjustment practice is responsible for differences in the quality of anticoagulation control between centers and countries: an analysis of patients receiving warfarin in the randomized evaluation of long-term anticoagulation therapy (RE-LY) trial.

Van Spall HG, Wallentin L, Yusuf S, Eikelboom JW, Nieuwlaat R, Yang S, Kabali C, Reilly PA, Ezekowitz MD, Connolly SJ.

Circulation. 2012 Nov 6;126(19):2309-16. doi: 10.1161/CIRCULATIONAHA.112.101808. Epub 2012 Oct 1.

9.

Patient factors against stable control of warfarin therapy for Japanese non-valvular atrial fibrillation patients.

Tomita H, Kadokami T, Momii H, Kawamura N, Yoshida M, Inou T, Fukuizumi Y, Usui M, Funakoshi K, Yamada S, Aomori T, Yamamoto K, Uno T, Ando S; ATTACK-WF research group.

Thromb Res. 2013 Nov;132(5):537-42. doi: 10.1016/j.thromres.2013.09.003. Epub 2013 Sep 10.

PMID:
24071466
10.

A prospective study of an aggressive warfarin dosing algorithm to reach and maintain INR 2 to 3 after heart valve surgery.

Meijer K, Kim YK, Carter D, Schulman S.

Thromb Haemost. 2011 Feb;105(2):232-8. doi: 10.1160/TH10-05-0324. Epub 2010 Dec 21.

PMID:
21173999
11.

Efficacy and safety of a pharmacist-managed inpatient anticoagulation service for warfarin initiation and titration.

Wong YM, Quek YN, Tay JC, Chadachan V, Lee HK.

J Clin Pharm Ther. 2011 Oct;36(5):585-91. doi: 10.1111/j.1365-2710.2010.01216.x. Epub 2010 Nov 12.

PMID:
21070296
12.

Decreasing warfarin sensitivity during the first three months after heart valve surgery: implications for dosing.

Meijer K, Kim YK, Schulman S.

Thromb Res. 2010 Mar;125(3):224-9. doi: 10.1016/j.thromres.2009.02.012. Epub 2009 Mar 31.

PMID:
19336266
13.

Time in the therapeutic range during warfarin therapy in Japanese patients with non-valvular atrial fibrillation. - A multicenter study of its status and infuential factors-.

Okumura K, Komatsu T, Yamashita T, Okuyama Y, Harada M, Konta Y, Hatayama T, Horiuchi D, Tsushima E.

Circ J. 2011;75(9):2087-94. Epub 2011 Jul 8.

14.

Efficacy of computer-aided dosing of warfarin among patients in a rehabilitation hospital.

Mitra R, Marciello MA, Brain C, Ahangar B, Burke DT.

Am J Phys Med Rehabil. 2005 Jun;84(6):423-7.

PMID:
15905656
15.

"Zeus" a new oral anticoagulant therapy dosing algorithm: a cohort study.

Cafolla A, Melizzi R, Baldacci E, Pignoloni P, Dragoni F, Campanelli M, Caraccini R, Foà R.

Thromb Res. 2011 Oct;128(4):325-30. doi: 10.1016/j.thromres.2011.04.012. Epub 2011 May 19.

PMID:
21600633
16.

Improving anticoagulation control in hospitalized elderly patients on warfarin.

Gouin-Thibault I, Levy C, Pautas E, Cambus JP, Drouet L, Mahé I, Bal Dit Sollier C, Horellou MH, Golmard JL, Siguret V.

J Am Geriatr Soc. 2010 Feb;58(2):242-7. doi: 10.1111/j.1532-5415.2009.02675.x. Epub 2010 Jan 26.

PMID:
20374400
17.

Defining time in therapeutic range for busy clinicians: frequency of dose changes is a good surrogate marker to identify patients with suboptimal anticoagulation with warfarin.

Vijenthira A, Le Gal G, Castellucci LA, Carrier M.

Thromb Res. 2014 Sep;134(3):584-6. doi: 10.1016/j.thromres.2014.06.024. Epub 2014 Jul 6.

PMID:
25037497
18.

Warfarin treatment quality is consistently high in both anticoagulation clinics and primary care setting in Sweden.

Björck F, Sandén P, Renlund H, Svensson PJ, Själander A.

Thromb Res. 2015 Aug;136(2):216-20. doi: 10.1016/j.thromres.2015.04.016. Epub 2015 Apr 22.

PMID:
25935649
19.

Warfarin for atrial fibrillation in community-based practise.

Rose AJ, Ozonoff A, Henault LE, Hylek EM.

J Thromb Haemost. 2008 Oct;6(10):1647-54.

PMID:
18853483
20.

The interval between prothrombin time tests and the quality of oral anticoagulants treatment in patients with chronic atrial fibrillation.

Shalev V, Rogowski O, Shimron O, Sheinberg B, Shapira I, Seligsohn U, Berliner S, Misgav M.

Thromb Res. 2007;120(2):201-6. Epub 2006 Nov 21.

PMID:
17118431
Items per page

Supplemental Content

Write to the Help Desk